Attovia Therapeutics, Inc. Common Stock (ATTO) Stock Price

ATTOStock

$19.31

Market Cap$830.89M

P/E0.00x

PEG Ratio—

Div yield—

Beta9589.88

ATTO Share Price Chart

Favorite Metrics

VGM Score37.66

P/E Ratio (Annual)0.00x

P/CF (Annual)0.00x

Book Value / Share (Quarterly)$2.08

P/TBV (Annual)15.57x

Revenue Growth (3Y)-7.28%

Cash Flow / Share (Quarterly)$-3.95

Price vs S&P 500 (YTD)-5.02%

Net Profit Margin (TTM)0.43%

EPS (TTM)$-13.88

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$-13.88

Revenue Growth (5Y)-3.78%

EPS (Annual)$-6.61

Dividend / Share (Annual)$0.00

ROI (Annual)2.34%

Net Profit Margin (5Y Avg)-2.87%

Cash / Share (Quarterly)$4.52

P/E Basic Excl Extra (TTM)0.00x

Revenue Growth QoQ (YoY)-5.93%

P/E Normalized (Annual)0.00x

ROA (Last FY)1.52%

Revenue Growth TTM (YoY)17.40%

EBITD / Share (TTM)$9.87

Operating Margin (TTM)2.29%

Cash Flow / Share (Annual)$-0.38

P/B Ratio (Quarterly)13.55x

Net Income / Employee (Annual)$-700

Net Interest Coverage (TTM)0.04x

ROA (TTM)0.15%

EPS Incl Extra (Annual)$-6.61

Current Ratio (Annual)1.15x

Quick Ratio (Quarterly)0.93x

3-Month Avg Trading Volume0.65M

P/E Incl Extra (TTM)0.00x

Revenue / Employee (TTM)$12,500

Tangible BV / Share (Quarterly)$0.87

P/S Ratio (Annual)0.00x

Asset Turnover (Annual)1.31x

52-Week High$24.32

Operating Margin (5Y Avg)2.84%

EPS Excl Extra (Annual)$-6.61

CapEx CAGR (5Y)-7.20%

Tangible BV CAGR (5Y)-40.21%

Quick Ratio (Annual)1.13x

Total Debt / Equity (Annual)6.08x

Current Ratio (Quarterly)0.95x

Enterprise Value$673.13M

Revenue / Share Growth (5Y)-2.93%

Asset Turnover (TTM)1.63x

Book Value / Share Growth (5Y)-21.67%

Revenue / Employee (Annual)$10,300

Pretax Margin (Annual)-6.11%

Cash / Share (Annual)$8.39

Net Income / Employee (TTM)$-1,400

EBITDA CAGR (5Y)-9.82%

EBITDA Interim CAGR (5Y)-6.73%

ROE (Last FY)5.58%

Net Interest Coverage (Annual)-0.05x

EPS Basic Excl Extra (Annual)$-6.61

P/FCF (TTM)0.00x

Receivables Turnover (TTM)6.04x

Total Debt / Equity (Quarterly)22.29x

EPS Incl Extra (TTM)$-13.88

Receivables Turnover (Annual)5.20x

ROI (TTM)0.27%

P/S Ratio (TTM)0.00x

Pretax Margin (5Y Avg)-1.98%

Revenue / Share (Annual)$103.06

Tangible BV / Share (Annual)$0.87

P/E Ratio (TTM)0.00x

Year-to-Date Return-5.84%

5-Day Price Return-11.27%

EPS Normalized (Annual)$-6.61

ROA (5Y Avg)2.79%

Net Profit Margin (Annual)-6.41%

Month-to-Date Return-5.84%

EBITD / Share (Annual)$9.77

Operating Margin (Annual)0.86%

LT Debt / Equity (Annual)4.14x

P/CF (TTM)0.00x

ROI (5Y Avg)4.79%

P/E Excl Extra (TTM)0.00x

LT Debt / Equity (Quarterly)15.65x

EPS Basic Excl Extra (TTM)$-13.88

P/TBV (Quarterly)15.57x

Payout Ratio (Annual)12.43%

P/B Ratio (Annual)1.70x

Dividend / Share (TTM)$0.00

Pretax Margin (TTM)4.32%

Book Value / Share (Annual)$7.98

Dividend Yield (TTM)0.00%

Beta9589.88x

P/FCF (Annual)0.00x

Revenue / Share (TTM)$119.93

ROE (TTM)6.41%

52-Week Low$16.15

vGradeB

gGradeD

mGradeF

vgmGradeD

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
ATTOAttovia Therapeutics, Inc. Common Stock	B	D	F	$19.31
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Attovia Therapeutics, Inc. Common Stock

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.